← Back to Clinical Trials
Recruiting NCT06013852

NCT06013852 Boneview-ED - Impact of Artificial Intelligence Detecting Fractures in the Emergence Department : a Pragmatic Prospective Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06013852
Status Recruiting
Phase
Sponsor University Hospital, Angers
Condition Fractures, Bone
Study Type INTERVENTIONAL
Enrollment 1,600 participants
Start Date 2024-07-22
Primary Completion 2025-01-21

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
processing the radiography with the "Boneview" software

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 1,600 participants in total. It began in 2024-07-22 with a primary completion date of 2025-01-21.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Traumatic emergencies are the primary reason for consultation in emergency departments and standard radiography is the primary imaging exam for osteoarticular trauma. However, with the increase in the number of patients admitted to emergency departments and thus the increased workload for emergency room attendants, Interpretation of radiographs in trauma emergencies is made more difficult, resulting in a high risk of misinterpretation. The growing presence of artificial intelligence in the medical field, notably through the involvement of diagnostic software on imageries, makes its use more relevant in the aid of the replay of osteoarticular imageries. A recent meta-analysis of 32 studies evaluating the performance of artificial intelligence in fracture detection found comparable performance between experienced radiologists and AI-based diagnosis. However, these were mainly retrospective studies, and thus more distant from the reality of its use in a care stream such as emergencies. The objective of this study is therefore to prospectively validate the use of artificial intelligence software during its implementation in an emergency department for patients admitted for a suspicion of osteoarticular trauma.

Eligibility Criteria

Inclusion Criteria: * Major patient * Admitted to the emergency department after trauma less than 48 hours * Patient with an indication on an x-ray of the limbs or/and pelvis * Express patient consent * Affiliated patient or social security beneficiary Exclusion Criteria: * Polytraumatized patient * X-ray of the corso-lumbar spine, skull, cervical spine (all parts of the body not affected by the intended use of the software) * Pregnant, lactating or parturient patient

Contact & Investigator

Central Contact

Damien Combes, Dr

✉ damien.combe@chu-angers.fr

📞 (0)2 41 35 42 81

Principal Investigator

Damien Combes, Dr

PRINCIPAL INVESTIGATOR

University hospital of Angers

Frequently Asked Questions

Who can join the NCT06013852 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Fractures, Bone. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06013852 currently recruiting?

Yes, NCT06013852 is actively recruiting participants. Contact the research team at damien.combe@chu-angers.fr for enrollment information.

Where is the NCT06013852 trial being conducted?

This trial is being conducted at Angers, France.

Who is sponsoring the NCT06013852 clinical trial?

NCT06013852 is sponsored by University Hospital, Angers. The principal investigator is Damien Combes, Dr at University hospital of Angers. The trial plans to enroll 1,600 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology